Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

Novavax will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan * Matrix-M adjuvant to be supplied from Novavax * Government of Japan will provide …
( read original story …)